Albemarle (ALB) Stock Forecast, Price Target & Predictions
ALB Stock Forecast
Albemarle stock forecast is as follows: an average price target of $193.85 (represents a 121.69% upside from ALB’s last price of $87.44) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.
ALB Price Target
The average price target for Albemarle (ALB) is $193.85 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $320.00 to $83.00. This represents a potential 121.69% upside from ALB's last price of $87.44.
ALB Analyst Ratings
According to 18 Wall Street analysts, Albemarle's rating consensus is 'Buy'. The analyst rating breakdown for ALB stock is 0 'Strong Buy' (0.00%), 11 'Buy' (61.11%), 5 'Hold' (27.78%), 2 'Sell' (11.11%), and 0 'Strong Sell' (0.00%).
Albemarle Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 16, 2024 | Joel Jackson | BMO Capital | $150.00 | $77.81 | 92.78% | 71.55% |
| Aug 08, 2024 | Charles Neivert | Piper Sandler | $90.00 | $80.39 | 11.95% | 2.93% |
| Aug 06, 2024 | Arun Viswanathan | RBC Capital | $111.00 | $81.05 | 36.95% | 26.94% |
| Aug 05, 2024 | Aleksey Yefremov | KeyBanc | $132.00 | $83.80 | 57.52% | 50.96% |
| Jul 31, 2024 | Andres Castanos-Mollor | Berenberg Bank | $83.00 | $92.51 | -10.28% | -5.08% |
| Jun 25, 2024 | Charles Neivert | Piper Sandler | $95.00 | $92.77 | 2.40% | 8.65% |
| Jun 13, 2024 | Joshua Spector | UBS | $124.00 | $112.65 | 10.08% | 41.81% |
| Jun 12, 2024 | Bill Selesky | Argus Research | $166.00 | $112.65 | 47.36% | 89.84% |
| May 30, 2024 | Charles Neivert | Piper Sandler | $122.00 | $124.38 | -1.91% | 39.52% |
| May 21, 2024 | Ben Isaacson | Scotiabank | $135.00 | $127.50 | 5.89% | 54.39% |
The latest Albemarle stock forecast, released on Aug 16, 2024 by Joel Jackson from BMO Capital, set a price target of $150.00, which represents a 92.78% increase from the stock price at the time of the forecast ($77.81), and a 71.55% increase from ALB last price ($87.44).
Albemarle Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 6 | 18 |
| Avg Price Target | $150.00 | $110.17 | $145.56 |
| Last Closing Price | $87.44 | $87.44 | $87.44 |
| Upside/Downside | 71.55% | 25.99% | 66.47% |
In the current month, the average price target of Albemarle stock is $150.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 71.55% increase as opposed to Albemarle's last price of $87.44. This month's average price target is up 36.15% compared to last quarter, and up 3.05% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 16, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Aug 08, 2024 | Piper Sandler | Underweight | Underweight | Hold |
| Aug 06, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Aug 05, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Jul 31, 2024 | Wells Fargo | Sector Perform | Sector Perform | Hold |
| Jul 31, 2024 | UBS | Underperform | Underperform | Hold |
| Jul 17, 2024 | HSBC | - | Hold | Downgrade |
| Jul 10, 2024 | Wells Fargo | Sector Perform | Equal-Weight | Downgrade |
| Jul 09, 2024 | Wells Fargo | Sector Perform | Sector Perform | Hold |
| Jun 25, 2024 | Piper Sandler | Underweight | Underweight | Hold |
Albemarle's last stock rating was published by BMO Capital on Aug 16, 2024. The company gave ALB a "Outperform" rating, the same as its previous rate.
Albemarle Financial Forecast
Albemarle Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.31B | $2.37B | $2.58B | $2.62B | $2.09B | - | $1.13B | $894.20M | $830.57M | $773.90M | $829.29M | $879.15M | $746.87M | $764.05M | $738.85M | $992.56M | $879.75M |
| Avg Forecast | $1.91B | $1.73B | $1.63B | $1.48B | $1.66B | $1.55B | $1.49B | $1.37B | $1.47B | $1.40B | $1.34B | $1.29B | $2.18B | $2.52B | $2.42B | $2.71B | $2.62B | $2.22B | $1.43B | $1.04B | $897.26M | $765.09M | $786.42M | $758.48M | $853.25M | $734.69M | $710.17M | $762.58M | $1.00B | $882.41M |
| High Forecast | $2.14B | $1.93B | $1.82B | $1.65B | $1.86B | $1.73B | $1.66B | $1.52B | $1.64B | $1.56B | $1.49B | $1.45B | $2.31B | $2.91B | $2.70B | $3.03B | $2.93B | $2.48B | $1.43B | $1.26B | $1.09B | $927.91M | $953.78M | $919.89M | $1.03B | $891.03M | $861.30M | $924.86M | $1.22B | $1.07B |
| Low Forecast | $1.63B | $1.47B | $1.38B | $1.26B | $1.41B | $1.32B | $1.27B | $1.16B | $1.25B | $1.20B | $1.13B | $1.10B | $2.10B | $2.06B | $2.05B | $2.30B | $2.23B | $1.89B | $1.43B | $849.99M | $736.07M | $627.65M | $645.15M | $622.22M | $699.97M | $602.71M | $582.59M | $625.59M | $822.94M | $723.89M |
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 3 | 6 | 16 | 8 | 9 | 12 | 7 | 7 | 10 | 15 | 8 | 8 | 8 | 12 | 8 | 8 | 13 | 7 | 12 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 0.98% | 0.95% | 1.00% | 0.94% | - | 1.09% | 1.00% | 1.09% | 0.98% | 1.09% | 1.03% | 1.02% | 1.08% | 0.97% | 0.99% | 1.00% |
Albemarle's average Quarter revenue forecast for Dec 23 based on 6 analysts is $2.18B, with a low forecast of $2.10B, and a high forecast of $2.31B. ALB's average Quarter revenue forecast represents a -5.77% decrease compared to the company's last Quarter revenue of $2.31B (Sep 23).
Albemarle EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 3 | 6 | 16 | 8 | 9 | 12 | 7 | 7 | 10 | 15 | 8 | 8 | 8 | 12 | 8 | 8 | 13 | 7 | 12 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-140.01M | $287.04M | $1.27B | $887.13M | $976.66M | - | $402.45M | $84.74M | $-440.23M | $600.16M | $223.93M | $155.46M | $206.86M | $176.75M | $196.22M | $164.45M | $246.01M |
| Avg Forecast | $366.15M | $330.46M | $311.16M | $282.70M | $317.99M | $296.84M | $284.90M | $261.21M | $280.89M | $266.91M | $255.45M | $307.78M | $416.52M | $481.96M | $462.39M | $279.80M | $501.40M | $-367.55M | $273.00M | $254.36M | $80.33M | $-290.55M | $556.77M | $139.95M | $145.56M | $124.65M | $145.27M | $156.03M | $165.40M | $250.74M |
| High Forecast | $408.78M | $368.94M | $347.40M | $315.62M | $355.02M | $331.41M | $318.07M | $291.62M | $313.59M | $297.63M | $285.19M | $369.34M | $441.98M | $557.08M | $516.23M | $335.76M | $559.78M | $-294.04M | $273.00M | $305.24M | $96.39M | $-232.44M | $668.13M | $167.94M | $174.68M | $149.58M | $174.33M | $187.24M | $198.48M | $300.88M |
| Low Forecast | $311.09M | $280.77M | $264.38M | $240.19M | $270.18M | $252.21M | $242.06M | $221.93M | $238.65M | $230.43M | $217.04M | $246.23M | $401.97M | $394.02M | $392.87M | $223.84M | $426.00M | $-441.06M | $273.00M | $203.49M | $64.26M | $-348.66M | $445.42M | $111.96M | $116.45M | $99.72M | $116.22M | $124.83M | $132.32M | $200.59M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.29% | 0.62% | 4.54% | 1.77% | -2.66% | - | 1.58% | 1.05% | 1.52% | 1.08% | 1.60% | 1.07% | 1.66% | 1.22% | 1.26% | 0.99% | 0.98% |
16 analysts predict ALB's average Quarter EBITDA for Sep 23 to be $481.96M, with a high of $557.08M and a low of $394.02M. This is 67.91% upper than Albemarle's previous annual EBITDA (Jun 23) of $287.04M.
Albemarle Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 3 | 6 | 16 | 8 | 9 | 12 | 7 | 7 | 10 | 15 | 8 | 8 | 8 | 12 | 8 | 8 | 13 | 7 | 12 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $302.53M | $650.04M | $880.51M | $838.99M | $672.32M | - | $253.38M | $-23.09M | $-402.14M | $424.60M | $95.68M | $58.53M | $98.30M | $85.62M | $107.20M | $90.39M | $155.07M |
| Avg Forecast | $175.10M | $156.43M | $120.68M | $81.16M | $98.11M | $92.18M | $81.77M | $50.20M | $-7.32M | $-29.69M | $50.16M | $182.08M | $115.60M | $441.06M | $526.61M | $165.52M | $970.83M | $-327.93M | $365.20M | $150.48M | $-3.62M | $-259.24M | $393.91M | $59.80M | $79.25M | $59.23M | $70.38M | $85.25M | $90.91M | $158.05M |
| High Forecast | $201.61M | $180.11M | $138.94M | $93.45M | $112.96M | $106.13M | $94.14M | $57.80M | $-5.89M | $603.72M | $57.75M | $218.49M | $188.00M | $890.84M | $606.33M | $198.63M | $1.12B | $-262.35M | $365.20M | $180.57M | $-2.90M | $-207.39M | $472.69M | $71.76M | $95.10M | $71.08M | $84.45M | $102.30M | $109.09M | $189.66M |
| Low Forecast | $140.87M | $125.85M | $97.09M | $65.30M | $78.93M | $74.16M | $65.78M | $40.39M | $-8.42M | $-1.07B | $40.36M | $145.66M | $22.19M | $236.32M | $423.67M | $132.42M | $781.06M | $-393.52M | $365.20M | $120.38M | $-4.35M | $-311.08M | $315.12M | $47.84M | $63.40M | $47.39M | $56.30M | $68.20M | $72.73M | $126.44M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 1.23% | 5.32% | 0.86% | -2.05% | - | 1.68% | 6.37% | 1.55% | 1.08% | 1.60% | 0.74% | 1.66% | 1.22% | 1.26% | 0.99% | 0.98% |
Albemarle's average Quarter net income forecast for Dec 23 is $115.60M, with a range of $22.19M to $188.00M. ALB's average Quarter net income forecast represents a -61.79% decrease compared to the company's last Quarter net income of $302.53M (Sep 23).
Albemarle SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 3 | 6 | 16 | 8 | 9 | 12 | 7 | 7 | 10 | 15 | 8 | 8 | 8 | 12 | 8 | 8 | 13 | 7 | 12 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $173.87M | $397.07M | $154.31M | $148.16M | $134.48M | - | $112.57M | $123.30M | $103.48M | $121.52M | $93.19M | $124.91M | $96.09M | $106.95M | $101.88M | $185.16M | $108.14M |
| Avg Forecast | $222.45M | $200.76M | $189.04M | $171.75M | $193.19M | $180.34M | $173.08M | $158.69M | $170.65M | $162.16M | $155.19M | $80.89M | $253.05M | $292.80M | $280.92M | $73.54M | $304.61M | $86.39M | $165.85M | $66.85M | $116.88M | $68.29M | $112.73M | $58.24M | $116.96M | $57.90M | $87.90M | $81.01M | $186.23M | $110.21M |
| High Forecast | $248.35M | $224.14M | $211.05M | $191.75M | $215.68M | $201.34M | $193.24M | $177.17M | $190.52M | $180.82M | $173.26M | $97.07M | $268.52M | $338.44M | $313.63M | $88.24M | $340.08M | $103.67M | $165.85M | $80.22M | $140.26M | $81.95M | $135.28M | $69.89M | $140.35M | $69.48M | $105.48M | $97.21M | $223.47M | $132.26M |
| Low Forecast | $189.00M | $170.58M | $160.62M | $145.93M | $164.14M | $153.22M | $147.06M | $134.83M | $144.99M | $139.99M | $131.86M | $64.71M | $244.21M | $239.38M | $238.68M | $58.83M | $258.81M | $69.11M | $165.85M | $53.48M | $93.50M | $54.64M | $90.19M | $46.59M | $93.57M | $46.32M | $70.32M | $64.81M | $148.98M | $88.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.59% | 1.41% | 2.10% | 0.49% | 1.56% | - | 1.68% | 1.05% | 1.52% | 1.08% | 1.60% | 1.07% | 1.66% | 1.22% | 1.26% | 0.99% | 0.98% |
Albemarle's average Quarter SG&A projection for Dec 23 is $253.05M, based on 6 Wall Street analysts, with a range of $244.21M to $268.52M. The forecast indicates a 45.54% rise compared to ALB last annual SG&A of $173.87M (Sep 23).
Albemarle EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 3 | 6 | 16 | 8 | 9 | 12 | 7 | 7 | 10 | 15 | 8 | 8 | 8 | 12 | 8 | 8 | 13 | 7 | 12 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.58 | $5.54 | $7.51 | $7.16 | $5.74 | - | $2.16 | $-0.20 | $-3.44 | $3.63 | $0.85 | $0.55 | $0.92 | $0.81 | $1.01 | $0.85 | $1.46 |
| Avg Forecast | $1.49 | $1.33 | $1.03 | $0.69 | $0.83 | $0.78 | $0.70 | $0.43 | $-0.06 | $-0.25 | $0.43 | $0.25 | $0.98 | $3.75 | $4.48 | $7.27 | $8.26 | $6.97 | $3.11 | $1.64 | $1.00 | $0.77 | $0.84 | $0.80 | $1.10 | $0.78 | $0.74 | $0.82 | $1.74 | $1.56 |
| High Forecast | $1.72 | $1.53 | $1.18 | $0.80 | $0.96 | $0.90 | $0.80 | $0.49 | $-0.05 | $5.14 | $0.49 | $0.29 | $1.60 | $7.58 | $5.16 | $8.37 | $9.51 | $8.03 | $3.11 | $2.09 | $1.27 | $0.98 | $1.07 | $1.02 | $1.40 | $1.00 | $0.94 | $1.05 | $2.22 | $1.99 |
| Low Forecast | $1.20 | $1.07 | $0.83 | $0.56 | $0.67 | $0.63 | $0.56 | $0.34 | $-0.07 | $-9.09 | $0.34 | $0.20 | $0.19 | $2.01 | $3.60 | $5.85 | $6.65 | $5.61 | $3.11 | $1.26 | $0.76 | $0.59 | $0.64 | $0.61 | $0.84 | $0.60 | $0.57 | $0.63 | $1.34 | $1.20 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 1.24% | 1.03% | 0.87% | 0.82% | - | 1.32% | -0.20% | -4.48% | 4.33% | 1.07% | 0.50% | 1.18% | 1.10% | 1.23% | 0.49% | 0.93% |
According to 6 Wall Street analysts, Albemarle's projected average Quarter EPS for Dec 23 is $0.98, with a low estimate of $0.19 and a high estimate of $1.60. This represents a -61.88% decrease compared to ALB previous annual EPS of $2.58 (Sep 23).
Albemarle Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| GEVO | Gevo | $1.17 | $2.92 | 149.57% | Buy |
| ALB | Albemarle | $87.44 | $193.85 | 121.69% | Buy |
| LTHM | Livent | $16.51 | $27.33 | 65.54% | Buy |
| PPG | PPG Industries | $126.98 | $162.41 | 27.90% | Buy |
| SQM | Sociedad Química y Minera de Chile | $38.23 | $45.75 | 19.67% | Buy |
| DD | DuPont de Nemours | $81.42 | $93.29 | 14.58% | Buy |
| LYB | LyondellBasell Industries | $93.18 | $102.47 | 9.97% | Buy |
| APD | Air Products and Chemicals | $284.13 | $300.08 | 5.61% | Hold |
| ECL | Ecolab | $250.54 | $240.72 | -3.92% | Buy |
| SHW | Sherwin-Williams Company | $375.40 | $340.79 | -9.22% | Buy |
| LIN | Linde | $468.81 | $424.58 | -9.43% | Buy |
ALB Forecast FAQ
Is Albemarle a good buy?
Yes, according to 18 Wall Street analysts, Albemarle (ALB) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 11 'Buy' recommendations, accounting for 61.11% of ALB's total ratings.
What is ALB's price target?
Albemarle (ALB) average price target is $193.85 with a range of $83 to $320, implying a 121.69% from its last price of $87.44. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Albemarle stock go up soon?
According to Wall Street analysts' prediction for ALB stock, the company can go up by 121.69% (from the last price of $87.44 to the average price target of $193.85), up by 265.97% based on the highest stock price target, and down by -5.08% based on the lowest stock price target.
Can Albemarle stock reach $130?
ALB's average twelve months analyst stock price target of $193.85 supports the claim that Albemarle can reach $130 in the near future.
What is Albemarle's current price target trend?
1 Wall Street analyst forecast a $150 price target for Albemarle (ALB) this month, up 71.55% from its last price of $87.44. Compared to the last 3 and 12 months, the average price target increased by 25.99% and increased by 66.47%, respectively.
What are Albemarle's analysts' financial forecasts?
Albemarle's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $6.07B (high $6.78B, low $5.16B), average EBITDA is $1.16B (high $1.3B, low $986.37M), average net income is $322.25M (high $371.03M, low $259.26M), average SG&A $705.3M (high $787.43M, low $599.25M), and average EPS is $2.74 (high $3.16, low $2.21). ALB's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $6.75B (high $7.53B, low $5.73B), average EBITDA is $1.29B (high $1.44B, low $1.1B), average net income is $533.38M (high $614.11M, low $429.11M), average SG&A $784M (high $875.29M, low $666.12M), and average EPS is $4.54 (high $5.23, low $3.65).
Did the ALB's actual financial results beat the analysts' financial forecasts?
Based on Albemarle's last annual report (Dec 2022), the company's revenue was $7.32B, beating the average analysts forecast of $7.31B by 0.19%. Apple's EBITDA was $2.87B, beating the average prediction of $661.21M by 333.40%. The company's net income was $2.04B, beating the average estimation of $1.16B by 76.33%. Apple's SG&A was $524.14M, missing the average forecast of $623.71M by -15.96%. Lastly, the company's EPS was $17.44, missing the average prediction of $19.98 by -12.70%. In terms of the last quarterly report (Sep 2023), Albemarle's revenue was $2.31B, missing the average analysts' forecast of $2.52B by -8.28%. The company's EBITDA was $-140M, missing the average prediction of $481.96M by -129.05%. Albemarle's net income was $302.53M, missing the average estimation of $441.06M by -31.41%. The company's SG&A was $173.87M, missing the average forecast of $292.8M by -40.62%. Lastly, the company's EPS was $2.58, missing the average prediction of $3.75 by -31.25%